糖抗原125(CA125)多克隆抗體(生物素標記)
Biotin-Linked Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)
MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125
- 編號LAA154Mu71
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源抗體標記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物生物素
- 原抗體 PAA154Mu01-糖抗原125(CA125)多克隆抗體
- 緩沖液成份磷酸鹽緩沖液（pH7.4, 含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 641 ¥ 1495 ¥ 2136 ¥ 5340 ¥ 21360
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對CA125的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CA125。
用法
Western blotting: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA154Mu01 | 糖抗原125(CA125)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA154Mu02 | 糖抗原125(CA125)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA154Mu01 | 糖抗原125(CA125)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA154Mu02 | 糖抗原125(CA125)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA154Mu71 | 糖抗原125(CA125)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEA154Mu | 糖抗原125(CA125)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA154Mu | 糖抗原125(CA125)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| PLoS One | Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice. [pubmed:27755542] |
| Tumor Biology | KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis [pubmed:28651492] |
| Oncotarget | Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer [Pubmed:29484129] |
| Prognostic value of STC1 expression in ovarian cancer [] | |
| American Journal of Translational Research | Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway [Pubmed:35422913] |
留言咨詢
